Clinical Trials Sponsored by Ossi Hannula
Total 130 results
-
Ossi HannulaUniversity of Eastern FinlandCompletedPneumothorax | Gallbladder Diseases | Ascites | Deep Vein Thrombosis | Hydronephrosis | Pregnancy, Ectopic | Pleural Effusion | Abdominal Aortic Aneurism | Pericardial EffusionFinland
-
Orsi AcademyEnrolling by invitation
-
OSI PharmaceuticalsCompletedLocally Advanced or Metastatic Adenoca of the Biliary TractUnited States, Belgium, Germany, Poland, Romania, Switzerland
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
OSI PharmaceuticalsCompletedLocally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line TherapyUnited States
-
OSI PharmaceuticalsCompletedGastric Adenocarcinoma | Gastroesophageal AdenocarcinomaUnited States, United Kingdom, Belgium
-
Stefano PuliattiCompleted
-
Arvi Yli-HankalaTampere University HospitalCompletedAnaesthesia | SurgeryFinland
-
Enliten AICSSi Life SciencesRecruiting
-
Arion BioCSSi Life SciencesCompleted
-
Arion BioCSSi Life SciencesCompleted
-
Nasser HannaCompletedNeoplasms, Germ Cell and EmbryonalUnited States
-
Mayo ClinicOSI PharmaceuticalsCompleted
-
Emory UniversityOSI PharmaceuticalsTerminatedLiver CancerUnited States
-
Indiana UniversityOSI PharmaceuticalsCompletedLeukemia, Myelomonocytic, AcuteUnited States
-
Northwestern UniversityOSI PharmaceuticalsWithdrawn
-
Emory UniversityOSI PharmaceuticalsWithdrawnNeoplasms | Cancer | TumorsUnited States
-
Arvi Yli-HankalaCompleted
-
BioTeke USA, LLCCSSi Life SciencesCompleted
-
Hanna van EijsdenNot yet recruitingVestibular DisorderNetherlands
-
Hanna JangöCompletedQuality of Life | Pelvic Floor Disorders | Anal Incontinence | Anal Sphincter TearDenmark
-
Nasser HannaCompletedTestis Cancer | Testicular Cancer | Germ Cell TumorUnited States
-
University of ArkansasOSI PharmaceuticalsTerminated
-
OSI PharmaceuticalsTerminatedRecurrent or Refractory Pediatric EpendymomaUnited States, Canada, United Kingdom
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
NYU Langone HealthOSI PharmaceuticalsTerminated
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
OSI PharmaceuticalsCompleted
-
OSI PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States, United Kingdom
-
OSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompletedSCLC | Carcinoma, Small CellUnited Kingdom, United States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedOvarian NeoplasmsUnited Kingdom, United States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Medical Group Care, LLCCSSi Life SciencesCompletedCOVID-19 | Influenza A | Influenza BUnited States
-
University of PittsburghOSI PharmaceuticalsCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
OSI PharmaceuticalsCompletedAdvanced Pancreatic CancerUnited States
-
University of WashingtonOSI PharmaceuticalsCompletedProstate CancerUnited States
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
University of PittsburghOSI PharmaceuticalsWithdrawnSkin RashUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Freedom For All DiagnosticsCSSi Life SciencesCompleted
-
Hanna HolmbergUniversity of SalfordCompletedPhysical EnduranceUnited Kingdom